Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0362235 ADENYLYL CYCLASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF USE THEREOF
The present invention relates to novel adenine based inhibitors of adenylyl cyclase of the formula: ##STR00001## wherein X, L, R1, R2, R5 are those defined...
2017/0362234 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS
The present invention relates to novel substituted bridged urea analog compounds of Formula (I) or pharmaceutically acceptable salts thereof, corresponding...
2017/0362233 PROCESS FOR THE PREPARATION OF TERT-BUTYL ...
The present invention relates to processes for preparing compounds of Formula I. Such compounds include intermediates in the manufacture of ...
2017/0362232 PROCESS FOR THE PREPARATION OF APIXABAN AND INTERMEDIATES THEREOF
The present invention refers to novel process for the preparation of Apixaban. Further, the invention also related to a process for the preparation of...
2017/0362231 HETEROCYCLIC COMPOUNDS AND USES THEREOF
Provided herein are heterocyclic compounds of Formula (I), pharmaceutical compositions containing such a compound and their therapeutic uses, methods for their...
2017/0362230 SALTS, CO-CRYSTALS, AND POLYMORPHS OF AN ANXIOLYTIC COMPOUND
The present invention provides crystalline Forms FUM-P3, FUM-P4, MLA-P3 and MLA-P4 of compound formula 1 and related methods of treating and/or preventing a...
2017/0362229 CRYSTALLINE SOLID FORMS OF A BET INHIBITOR
The present application relates to crystalline solid forms of an inhibitor of BET proteins such as BRD2, BRD3, BRD4, and BRD-t, including methods of...
2017/0362228 TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
Described herein are tetrahydro-pyrido[3,4-b]indol-1-yl compounds with estrogen receptor modulation activity or function having the Formula I structure: ...
2017/0362227 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
The present invention discloses compounds according to Formula I: ##STR00001## Wherein R.sup.1a, R.sup.1b, R.sup.2, R.sup.4, R.sup.5, R.sup.6a, R.sup.6b,...
2017/0362226 RADIOACTIVE HALOGEN-LABELED PYRIDO [1,2-A] BENZIMIDAZOLE DERIVATIVE COMPOUND
The present invention relates to a radioactive halogen-labeled pyrido[1,2-a]benzimidazole derivative compound represented by a specific general formula or a...
2017/0362225 BICYCLIC COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF
The present disclosure relates to a class of substituted bicyclic compounds of formula (I), their tautomers, polymorphs, stereoisomers, prodrugs, solvates,...
2017/0362224 PESTICIDALLY ACTIVE POLYCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS
Polycyclic derivatives of formula (I), wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts salts, stereoisomers,...
2017/0362223 HETEROCYCLIC COMPOUND
Provided is a compound having an antagonistic action on an NMDA receptor containing the NR2B subunit, and is useful as a prophylactic or therapeutic agent for...
2017/0362222 1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF...
The present invention relates to novel 1,2,4-triazolo[4,3-a]pyridine compounds as positive allosteric modulators (PAMs) of the metabotropic glutamate receptor...
2017/0362221 INHIBITORS OF KIDNEY-TYPE GLUTAMINASE, GLS-1
The present invention relates generally to glutaminase inhibitors of Formula I, Formula II, or Formula III, as well as pharmaceutical compounds containing them...
2017/0362220 NOVEL TRICYCLIC COMPOUNDS AS INHIBITORS OF MUTANT IDH ENZYMES
The present invention is directed to tricyclic compounds of formula (I) which are inhibitors of one or more mutant IDH enzymes (I); wherein A is ...
2017/0362219 SUBSTITUTED DIHYDRO-1H-PYRROLO[3,2-C]PYRIDIN-4(5H)-ONES AS RIPK3 INHIBITORS
Compounds having Formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof, are useful as kinase modulators,...
2017/0362218 IMIDAZO[4,5-C]PYRIDINE DERIVED SSAO INHIBITORS
A compound as set out in claim 1, and the use of the same in therapy.
2017/0362217 Substituted Piperidine Compounds
The present disclosure provides substituted piperidine compounds having Formula (I), and the pharmaceutically acceptable salts and solvates thereof, wherein...
2017/0362216 HETEROCYCLIC INHIBITORS OF ERK1 AND ERK2 AND THEIR USE IN THE TREATEMENT OF CANCER
The present application provides novel heterocyclic compounds and pharmaceutically acceptable salts thereof. Also provided are methods for preparing these...
2017/0362215 1-METHYLPYRAZOLE-PIPERAZINE COMPOUNDS HAVING MULTIMODAL ACTIVITY AGAINST PAIN
The present invention relates to 1-methylpyrazole-piperazine compounds having dual pharmacological activity towards both the sigma (.sigma.) receptor, and the...
2017/0362214 DERIVATIVES OF 3-HETEROARYLISOXAZOL-5-CARBOXYLIC AMIDE USEFUL FOR THE TREATMENT OF INTER ALIA CYSTIC FIBROSIS
The present disclosure is based, in part, on the discovery that disclosed compounds can increase cystic fibrosis transmembrane conductance regulator (CFTR)...
2017/0362213 NITROCATECHOL DERIVATIVES AS COMT INHIBITORS
New compounds of formula I are described. The compounds have potentially valuable pharmaceutical properties in the treatment of some central and peripheral...
2017/0362212 PROCESS FOR PREPARATION OF LULICONAZOLE
A process for the preparation of luliconazole and salts thereof is disclosed.
2017/0362211 SMALL MOLECULE INHIBITORS OF FIBROSIS
Described herein are compounds and compositions for the treatment of a fibrotic disease.
2017/0362210 ANTI-ESTROGENIC COMPOUNDS
The present disclosure provides a compound of Formula I: ##STR00001## or a pharmaceutically acceptable salt wherein X, R.sup.1-R.sup.8, Y.sup.1-Y.sup.5, m, n, p,...
2017/0362209 PYRIDINE DERIVATIVES
The problem to be solved by the present invention is to provide a compound suitable for a pharmaceutical composition, specifically an agent for treating...
2017/0362208 NOVEL COMPOUNDS
There are provided inter alia compounds of formula (I) ##STR00001## wherein R.sup.1, R.sup.2a, R.sup.2b, R.sup.3, R.sup.4, L, X, R.sup.5 and R.sup.6 are as...
2017/0362207 PURIFIED CENICRIVIROC AND PURIFIED INTERMEDIATES FOR MAKING CENICRIVIROC
The disclosure includes high purity compounds having CCR5 and/or CCR2 antagonism, or salts thereof, high purity intermediates thereto and processes for...
2017/0362206 COMPOUNDS, COMPOSITIONS, AND METHODS
The present disclosure relates generally to LRRK2 inhibitors, or a pharmaceutically acceptable salt, deuterated analog, prodrug, tautomer, stereoisomer, or...
2017/0362205 2,3-DIHYDRO-ISOINDOLE-1-ONE DERIVATIVE AS BTK KINASE SUPPRESSANT, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME
The present invention provides a compound selected from the group consisting of a compound of formula (I), pharmaceutically acceptable salts, esters, prodrugs,...
2017/0362204 NOVEL PYRIMIDINES AS EGFR INHIBITORS AND METHODS OF TREATING DISORDERS
The application relates to a compound having Formula (I): ##STR00001## which modulates the activity of EGFR, a pharmaceutical composition comprising the...
2017/0362203 SUBSTITUTED 2-ANILINOPYRIMIDINE DERIVATIVES AS EGFR MODULATORS
This application discloses novel substituted 2-anilinopyrimidine derivatives, and pharmaceutically acceptable salts, solvates, prodrugs, and compositions...
2017/0362202 (S)-N-(3-(6-ISOPROPOXYPYRIDIN-3-YL)-1H-INDAZOL-5-YL)-1-(2-(4-(4-(1-METHYL-- ...
A composition comprising (S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2(4-(4-(1-methyl-- ...
2017/0362201 COT MODULATORS AND METHODS OF USE THEREOF
The present disclosure relates generally to modulators of Cot (cancer Osaka thyroid) and methods of use and manufacture thereof.
2017/0362200 Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity
This invention relates to a compound of formula I: ##STR00001## or a pharmaceutically acceptable salt thereof. Such compounds possess both muscarinic receptor...
2017/0362199 AMINOTRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
The present invention provides novel compounds having a P2X.sub.3 and/or P2X.sub.2/3 receptor antagonistic activity. A compound of Formula (I): ##STR00001## ...
2017/0362198 2,3,4,5-TETRAHYDROPYRIDIN-6-AMINE AND 3,4-DIHYDRO-2H-PYRROL-5-AMINE COMPOUND INHIBITORS OF BETA-SECRETASE
The present invention relates to 2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2H-pyrrol-5-amine compound inhibitors of beta-secretase having the structure...
2017/0362196 SUBSTITUTED BENZOTHIOPHENYL DERIVATIVES AS GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR40 receptor. Such compounds are...
2017/0362195 METHODS FOR THE MANUFACTURE OF CANNABINOID PRODRUGS, PHARMACEUTICAL FORMULATIONS AND THEIR USE
Described are methods for producing cannabinoid prodrugs as well as methods for formulating such prodrugs in a pharmaceutically acceptable form and their use...
2017/0362194 METHODS FOR CONVERTING CELLULOSE TO FURANIC PRODUCTS
The present invention relates to systems, methods, and processes for the production of conversion products such as furanic products from biomass such as...
2017/0362193 PROCESS FOR MANUFACTURING ETHYLENE OXIDE USING SCALED SELECTIVITY VALUES
Disclosed herein are methods of using scaled selectivities to assist in determining whether changes to the value of a target ethylene oxide production...
2017/0362192 PROCESS FOR PREPARING ATALUREN AND ITS INTERMEDIATES
The present invention provides processes for the preparation of ataluren. Intermediates for preparing ataluren are also provided.
2017/0362191 Substituted Cyclohexylamine Compounds
The present disclosure provides substituted cyclohexylamine compounds having Formula (I): and the pharmaceutically acceptable salts and solvates thereof,...
2017/0362190 Phosphoric Acid Loaded Covalent Organic Framework And A Process For The Preparation Thereof
The present invention is directed to a process for the preparation of phosphoric acid loaded covalent organic framework (PA@Tp-Azo and PA@Tp-Stb) with high...
2017/0362189 CRYSTALLINE FORMS OF TRISODIUM SUPRAMOLECULAR COMPLEX COMPRISING VALSARTAN AND AHU-377 AND METHODS THEREOF
Novel crystalline Forms of trisodium [3-((1S,3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butyl carbamoyl) ...
2017/0362188 INTEGRATED PRODUCTION OF UREA AND MELAMINE
Disclosed is a process for the integrated production of urea and melamine. A urea production zone produces a urea synthesis stream comprising urea, water and...
2017/0362187 3,5-DIAMINO-6-CHLORO-N-(N-(4-PHENYLBUTYL)CARBAMIMIDOYL) PYRAZINE-2- CARBOXAMIDE COMPOUNDS
The present invention relates compounds of the formula: ##STR00001## or pharmaceutically acceptable salts thereof, useful as sodium channel blockers, as well as...
2017/0362186 Salts of a dihydroquinazoline derivative
The invention relates to besylate and tosylate salts of {8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoro- ...
2017/0362185 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE
The present disclosure discloses compounds capable of modulating the activity of .alpha.-amino-.beta.-carboxymuconic acid semialdehyde decarboxylase (ACMSD),...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.